Login to Your Account



Biopharma firms take advantage of welcoming IPO market

By Peter Winter
BioWorld Insight Editor

Monday, July 17, 2017

The biopharma sector has taken advantage of renewed interest from investors and welcoming financial markets, with 25 companies focused on developing new medicines successfully completing their IPOs on U.S., European and Australasia exchanges in the first half of the year – 20 percent more than the total who graduated to the public ranks this time last year.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription